跳至主要内容
临床试验/NCT03930212
NCT03930212已完成4 期

Progesterone Supplementation in Threatened Abortion: Is it a Sound Practice?

Tanta University1 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
190
试验地点
1
主要终点
relief of pain

研究概览

简要总结

To decide whether progesterone supplementation in threatened abortion is a sound practice.

详细描述

This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • threatened abortion diagnosed by history and ultrasound examination
  • singleton
  • viable fetus
  • gestational age < 20 weeks
  • closed normal length cervix.

排除标准

  • short cervix <2 cm Multiple pregnancy
  • dead fetus
  • open cervix ≥ 2cm
  • history of cervical surgery
  • refusal to participate.

研究组 & 干预措施

Progesterone

Experimental

received rectal progesterone suppositories 400 mg once daily

干预措施: Progesterone (Drug)

Control group

Placebo Comparator

received placebo suppositories rectally once daily.

干预措施: Placebos (Drug)

结局指标

主要结局

relief of pain

时间窗: 3 weeks

questionnaire fulfilled by patient with yes or no questions

Stoppage of bleeding

时间窗: 3 weeks

Cessation of bleeding

completion of pregnancy beyond 20 weeks

时间窗: 12 weeks

passing the age 20 weeks

次要结局

  • abortion less than 20 weeks.(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman S Dawood, MD

Lecturer

Tanta University

研究点 (1)

Loading locations...

相似试验